- The article emphasizes that the true test in 2026 lies not within the prominent AI supply chains, but among marginalized assets referred to as "safety nets."
- It highlights various companies, from biotech firms like Arvinas and Tenaya Therapeutics achieving significant milestones, to financial entities like Markel Group adapting to challenging rates, showcasing a shift in survival strategies.
- The author argues against oversimplifying these diverse companies as merely "other" or "marginal," asserting they reflect critical operational realities in today's business landscape.
